Quantcast
Home / Opinion / Commentary / Reforming FDA, not price control, is path to cheaper drugs

Reforming FDA, not price control, is path to cheaper drugs

It is easy to see the political allure of “cheap drugs,” but what is often ignored by advocates of market distorting price controls is the long-term impact such policies will have on medical innovation and access.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

x

Check Also

On the Money Home Improvements

Lack of oversight, spiraling costs hinder low-income housing tax credit program

Americans are increasingly unable to cope with the ever-increasing costs of housing. Rising costs in Arizona and across our nation should be of interest to policymakers. One program that’s being used is the Low-Income Housing Tax Credit program.